Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (R)-4-((2-amino-9-(4-fluorobenzyl)-6-oxo-6,9-dihydro-1H-purin-8-ylthio)methyl)-2,5-dioxo-10,13,16-trioxa-3,6-diazanonadecan-19-ylcarbamate
ID: ALA5276813
Chembl Id: CHEMBL5276813
Max Phase: Preclinical
Molecular Formula: C44H63FN8O11S
Molecular Weight: 931.10
Associated Items: